# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Discover how GLP-1 drugs reshape consumer spending in food industries. Novo Nordisk's Wegvoy and Eli Lilly's Zepbound g...
Morgan Stanley analyst Brian Harbour maintains Sweetgreen (NYSE:SG) with a Underweight and raises the price target from $11 ...
TD Cowen analyst Andrew Charles reiterates Sweetgreen (NYSE:SG) with a Hold and maintains $22 price target.
TD Cowen analyst Andrew Charles maintains Sweetgreen (NYSE:SG) with a Hold and raises the price target from $17 to $22.
TD Cowen analyst Andrew Charles reiterates Sweetgreen (NYSE:SG) with a Hold and maintains $17 price target.
As of April 9, 2024, three stocks in the consumer discretionary sector could be flashing a real warning to investors who value ...
Oppenheimer analyst Brian Bittner maintains Sweetgreen (NYSE:SG) with a Outperform and raises the price target from $17 to $34.